DEF 14C

DEFINITIVE SCHEDULE 14C

Company: Sunshine Biopharma Inc.
Filed: May 4, 2010
Period of Report: May 4, 2010
Accession Number: 0001013596-10-000050

View Document ↗ View on SEC.gov ↗